Anixa Biosciences, Inc.
ANIX
$4.04
-$0.14-3.35%
NASDAQ
| 07/31/2025 | 04/30/2025 | 01/31/2025 | 10/31/2024 | 07/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -11.12M | -12.13M | -12.48M | -12.55M | -12.36M |
| Total Depreciation and Amortization | 36.00K | 30.00K | 33.00K | 37.00K | 40.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 3.71M | 4.12M | 4.21M | 4.66M | 4.88M |
| Change in Net Operating Assets | 528.00K | 3.00K | 315.00K | 526.00K | -935.00K |
| Cash from Operations | -6.85M | -7.98M | -7.93M | -7.34M | -8.38M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 5.08M | 8.64M | 6.85M | 4.28M | 2.82M |
| Cash from Investing | 5.08M | 8.64M | 6.85M | 4.28M | 2.82M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 2.06M | 292.00K | 3.38M | 3.45M | 3.73M |
| Repurchase of Common Stock | -36.00K | -36.00K | -33.00K | -33.00K | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 16.00K | 0.00 | -2.21M | 0.00 | -139.00K |
| Cash from Financing | 2.04M | 256.00K | 1.14M | 3.42M | 3.59M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 270.00K | 915.00K | 55.00K | 356.00K | -1.97M |